Human immunodeficiency virus neutralizing antibodies
US10882898B2 · kind B2 · utility
1Cited by
25References
77Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 12, 2019 |
| Grant date | Jan 5, 2021 |
| Priority date | — |
| Expiry date | Feb 12, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides novel anti-HIV antibodies with improved therapeutic properties, related pharmaceutical compositions, and methods of use thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.